Is This The Turnaround Cempra Has Been Looking For?
Shares of Cempra Inc. (NASDAQ: CEMP) saw an incredible gain on Friday after the company announced the results from its late-stage trial for the treatment of patients with acute bacterial skin and skin structure infections. Overall, fusidic acid was well tolerated in the study and achieved both primary and secondary endpoints.